Atossa Therapeutics, Inc. (ATOS)
NASDAQ·Healthcare·Biotechnology
$2.13
+0.47%
Mkt Cap $39.35M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$42.50
Range $10.00 – $75.00
Implied Upside
+1895.3%
Consensus $42.50 vs current $2.13
NASDAQ·Healthcare·Biotechnology
$2.13
+0.47%
Mkt Cap $39.35M
No recent rating data.
Price Target (2 analysts)
$42.50
Range $10.00 – $75.00
+1895.3%
Consensus $42.50 vs current $2.13